Ivermectin: facts and science are in its favour - Dr Nathi Mdladla, Dr Pinky Dr Ngcakani and Professor Colleen Aldous

Loading player...
In July, BizNews founder Alec Hogg spoke to Professor Colleen Aldous - an Associate Professor and Clinical Researcher at the University of KwaZulu-Natal who has boldly spoken out in favour of Ivermectin. Aldous stated clearly that she does not believe that Ivermectin is a 'miracle drug', but that there is more than enough evidence pointing towards its effectiveness. In July, BizNews published an article written by Professor Aldous in which she argued that the placement of our trust in a small group of experts who advocate against ivermectin is being done at the potential cost of human life. With the fact-based evidence in respect of Ivermectin's efficacy in the treatment of Covid-19 reaching an insurmountable level - one has to ask what the reasons are for the vehement argument against its use by institutions like the World Health Organisation. In this interview, BizNews spoke to Dr Nathi Mdladla, Dr Pinky Dr Ngcakani and Professor Colleen Aldous about the use of Ivermectin in conjunction with other alternative treatment as well as vaccination in order to treat Covid-19. Learn more about your ad choices. Visit megaphone.fm/adchoices
10 Aug 2021 8AM English South Africa Investing · Business News

Other recent episodes

BN Briefing: US Ambassador Bozell's BNC#8 warning; Yardeni's $6,000 Gold call; Sean Peche's wealth-building wisdom

Tonight’s BizNews Briefing opens with new US Ambassador Brent Bozell’s candid message from BNC#8, urging reciprocity and warning that policy uncertainty and geopolitical alignment choices shape investor confidence. We then run through a results-heavy market update led by Harmony, Rainbow Chicken and OUTsurance. Bloomberg follows with Ed Yardeni’s bullish gold…
11 Mar 7AM 10 min